These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 93514

  • 1. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL, Stewart J, Fox RM, Tattersall MH.
    Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
    [Abstract] [Full Text] [Related]

  • 2. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW, Halpin JJ, Smith RE, Batley F, Schuller DE.
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J, Oster MW.
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [Abstract] [Full Text] [Related]

  • 4. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA, MacRae K, Hill BT.
    Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557
    [Abstract] [Full Text] [Related]

  • 5. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC, Fabian RL.
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [Abstract] [Full Text] [Related]

  • 6. Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma.
    Wheeler RH, Liepman MK, Baker SR, Earhart RH, Bull FE, Ensminger WD.
    Cancer Treat Rep; 1980 Aug; 64(8-9):943-9. PubMed ID: 6160914
    [Abstract] [Full Text] [Related]

  • 7. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L, Gravenor D, Black M, Frenkiel S, Margolese R.
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Initial polychemotherapy in the treatment of cancers of the head and neck. The efficacy and tolerance of 2 nonrandomized combinations in 48 patients].
    Brun B, Mazeron JJ, Martin M, Lelièvre G, Langlois A, Feuillade F, Lebourgeois JP, Peynegre R, Grellet M, Pierquin B.
    Bull Cancer; 1984 Dec; 71(1):30-4. PubMed ID: 6201214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
    Chiuten D, Vogl SE, Kaplan BH, Greenwald E.
    Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy as the first line in the management of locally advanced epidermoid carcinoma of the head and neck region in Nigerians.
    Durosinmi-Etti FA, Campbell OB.
    Afr J Med Med Sci; 1988 Dec; 17(4):221-5. PubMed ID: 2469328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP, Skarin AT, Rosenthal DS, Moloney WC, Frei E.
    Cancer Treat Rep; 1981 Dec; 65 Suppl 1():125-9. PubMed ID: 6173118
    [Abstract] [Full Text] [Related]

  • 20. Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck.
    Merlano M, Rosso R, Sertoli MR, Benasso M, Bacigalupo A, Ardizzoni A, Mereu P, Margarino G, Scala M, Vitale V.
    Laryngoscope; 1990 May; 100(5):531-5. PubMed ID: 1691811
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.